Veterinary Diagnostics Market Size
Study Period | 2020 - 2029 |
Market Size (2024) | USD 7.94 Billion |
Market Size (2029) | USD 12.55 Billion |
CAGR (2024 - 2029) | 9.57 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Veterinary Diagnostics Market Analysis
The Veterinary Diagnostics Market size is estimated at USD 7.94 billion in 2024, and is expected to reach USD 12.55 billion by 2029, growing at a CAGR of 9.57% during the forecast period (2024-2029).
The outbreak of COVID-19 has had a substantial impact on the Veterinary Diagnostics Market because government regulations led to the suspension of various healthcare services, including Veterinary Diagnostic Services. For instance, an article published by the JAAWS in February 2022 reported that COVID-19 led to the shutting down of 70% of veterinary clinics in Canada and the US in 2020. Thus, initially, the studied market's growth was hampered due to the suspension of Veterinary Diagnostic Services to minimize COVID-19 infection. However, in the current scenario, it is anticipated that the decreasing COVID-19 cases leading to the resumption of Veterinary Diagnostic Services and a significant increase in pet adoption reported after the lockdown will lead to the stable growth of the Veterinary Diagnostics Market over the forecast period.
The factors driving the growth of the Veterinary Diagnostics Market are increased pet adoption and animal healthcare expenditure, rising incidence of zoonotic diseases, and the growing number of veterinary practitioners and disposable income in developing regions. For instance, in May 2022, Canada's 2021 Census of Agriculture report stated that farms in Canada reported a 3.4% increase in the number of hogs and pigs from the previous year (2020). In 2021, there were 14.6 million hogs and pigs in Canada, highlighting the growth potential in the Livestock Diagnostics Market. Similarly, the National Pet Owners Survey 2021-2022, conducted by the APPA, reported that the annual expenditure on routine visits for dogs accounts for USD 242 compared to USD 178 for cats in the United States. As a result, the increased pet and livestock adoption, coupled with increasing animal healthcare expenditure, are driving the growth of the Animal Diagnostics Market.
The number of zoonotic disease cases in animals has risen significantly in recent years. With the rise in the number of cases, the necessity to treat these disorders has also risen extensively, which is expected to propel the growth of the Animal Health Diagnostics Market. For instance, an article published by WHO in July 2022 reported that Africa is facing a growing risk of outbreaks caused by zoonotic pathogens, such as the monkeypox virus, which originated in animals and then switched species and infected humans. There has been a 63% increase in the number of zoonotic outbreaks in the region in the decade. The same source also reported that from 1 January 2022 to 8 July 2022, there have been 2,087 cumulative monkeypox cases, of which only 203 were confirmed. Thus, the increase in zoonotic diseases in animals is increasing the demand for Veterinary Diagnostics, thereby driving the growth of the Veterinary Diagnostics Market.
Furthermore, the expansion by the market players is also boosting the market's growth. For instance, in November 2021, Aviagen India expanded its Veterinary Diagnostic Laboratory in Tamil Nadu. The laboratory monitors the health of the Aviagen breeding stock regularly. Thus, such expansion increases the facility available for Veterinary Diagnosis and contributes to the market's growth.
Due to increased pet adoption and animal healthcare expenditure, rising incidence of zoonotic diseases, and growing investments by Veterinary Diagnostics Companies, the market is experiencing significant growth. However, the high cost of pet care and imaging devices and the lack of veterinarians are impeding the Veterinary Diagnostics Market growth.
Veterinary Diagnostics Market Trends
The Molecular Diagnostics Segment is Estimated to Witness Significant Growth Over the Forecast Period.
The molecular diagnostics segment is expected to witness significant growth over the forecast period due to livestock and pet owners' growing preference for quick test results and their cost-effectiveness. The segmental expansion is anticipated to be driven by the rising number of tests designed to identify prevalent animal diseases such as feline leukemia, canine parvovirus, heartworm, and infectious peritonitis. Furthermore, the increasing number of pet and livestock owners and the growing concern for their animal health, the rise in the prevalence of companion animal and livestock animal diseases, and the accessibility of affordable immunoassay tests that allow for frequent testing at home are also contributing to the growth of this segment.
The increasing cases of avian influenza in livestock animals are boosting the demand for molecular diagnostic tests, thereby driving the growth of this segment. For instance, in April 2022, as per the report published by the Government of Canada, various avian species—turkeys, ducks/chickens, geese, and peafowls—were infected by avian influenza in March 2022. The disease spreads rapidly among all livestock species, thus increasing molecular diagnostic tests for its detection, thereby contributing to the segment's growth.
Similarly, in July 2021, the European Pet Food Federation reported that between March 2020 and March 2021, it was estimated families adopted around 3.2 million pets in Britain. Thus, the high number of pet adoptions in European families is increasing awareness among pet owners about the health of pet animals, which is increasing the demand for Companion Animal Diagnostics, thereby contributing to the growth of this segment.
The launch of instruments and other products by market players is augmenting the market's growth. For instance, in August 2021, HORIBA UK Limited launched several new pathogen PCR tests for its POCKIT Central, an in-house Veterinary PCR System analyzer with the potential for fast, accurate PCR testing in every veterinary lab. Such launches are propelling the growth of the Veterinary Molecular Diagnostics Market.
Furthermore, in January 2022, Ringbio launched a professional website named petrapidtest.com to market Flexy Pet Rapid Test. These kits are based on lateral flow immunoassay, ELISA, and real-time PCR to detect companion animal diseases, which can be helpful for pet owners and vet clinics. Among these products, real-time PCR is specially designed for small vet clinics and can confirm infection of viruses, mycoplasma, and parasites. Such marketing initiatives taken by the players also augment the segment's growth.
Thus, with the increasing cases of avian influenza in livestock animals, increased pet adoption, and new product launches, the Veterinary Molecular Diagnostics Market is expected to show significant growth over the forecast period due to the abovementioned factors.
North America is Expected to Witness a Significant Growth Over the Forecast Period.
The North American region comprises the United States, Canada, and Mexico. The studied market is expected to witness significant growth in the region due to the increasing adoption of pet and livestock animals, availability of better diagnostics facilities, and technological developments due to the presence of key Veterinary Diagnostics Companies.
The increasing trend of livestock adoption also propels the market's growth in the region. For instance, in March 2022, USDA reported that in 2021, Mexico's cattle imports considerably increased. The source also reported a 5.4% growth in Mexico's livestock farming sector in 2021. Thus, the increasing livestock number in Mexico is boosting the Livestock Diagnostics Market, as there is an increasing risk of veterinary diseases, thereby driving the demand for Livestock Diagnosis Market solutions.
Moreover, the growing number of veterinary practitioners is also driving the growth of the studied market. For instance, in September 2022, the US Bureau of Labor Statistics reported that employment of veterinarians is projected to grow 19% from 2021 to 2031, much faster than the average for all occupations. Also, the same source reported that about 4,800 openings for veterinarians are projected each year, on average, over the decade. Thus, the increasing number of veterinary practitioners is leading to increased Veterinary Diagnostic Services, thereby driving the growth of the Veterinary Diagnostics Market.
The development of preventive diagnostic tools also contributes to the increasing number of veterinary visits and preventive care. For instance, in April 2021, Antech Diagnostics, a part of Mars Veterinary Health, released new data showing that all cats from a retrospective review of 730,000 veterinary visits received improved preventive care following a positive or negative RenalTech. RenalTech predicts CKD in cats two years before it occurs. The data shows that the predictive diagnostic tool increased veterinary visits by as much as 31%. Such studies and the development of predictive diagnostics tools are also driving the market growth in the country.
The increasing number of launches of diagnostic tests by market players is also propelling the market's growth. For instance, in July 2021, Vidium Animal Health launched SpotLight ePARR. It is a highly accurate and rapid molecular diagnostic test for canine lymphoma. Vidium developed it in collaboration with the Translational Genomics Research Institute (TGen), an affiliate of the City of Hope, and Ethos Discovery. Such advancements are strengthening the Veterinary Diagnostics Market in North America.
Thus, due to the increasing adoption of pet and livestock animals, availability of better diagnostics facilities, and technological developments, North America is expected to project significant growth over the forecast period.
Veterinary Diagnostics Industry Overview
The Veterinary Diagnostics Market is competitive and fragmented. The major market players are focusing on improved diagnostics techniques for animal care, especially protecting animals from diseases due to changing weather conditions. Some companies that provide Veterinary Diagnostic Services are bioMérieux SA, Heska Corporation, IDEXX Laboratories, IDvet, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Virbac Corporation, Zoetis Inc., BioChek BV, INDICAL Bioscience GmbH, Neogen Corporation, and Bio-Rad Laboratories Inc.
Veterinary Diagnostics Market Leaders
-
Idexx Laboratories
-
Zoetis, Inc
-
Thermo Fisher Scientific Inc
-
Biomérieux SA
-
Virbac Corporation
*Disclaimer: Major Players sorted in no particular order
Veterinary Diagnostics Market News
- In August 2022, PepiPets launched a new mobile diagnostic testing service. Launching this new service in a company release will allow clients to receive diagnostic testing at home for their pets. PepiPets hopes the at-home testing service will help pets feel more comfortable with the procedure and save time on travel to an in-person office visit.
- In March 2022, Companion Animal Health promulgated a strategic agreement, including an equity investment, with HT BioImaging to co-brand and exclusively sell the HTVet product in the US and Canada.
Veterinary Diagnostics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption of Pet Ownership and Animal Health Expenditure
4.2.2 Increased Burden of Animal Zonotic Diseases
4.2.3 Growing Pet Insurance and Animal Health Investments by Pharmaceutical Companies
4.3 Market Restraints
4.3.1 Lack of Veterinarians
4.3.2 High Cost of Pet Care and Imaging Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Instruments
5.1.2 Kits and Reagents
5.1.3 Software and Services
5.2 By Technology
5.2.1 Immunodiagnostics
5.2.2 Clinical Biochemistry
5.2.3 Molecular Diagnostics
5.2.4 Hematology
5.2.5 Other Technologies
5.3 By Animal Type
5.3.1 Companion Animals
5.3.1.1 Dogs
5.3.1.2 Cats
5.3.1.3 Other Companion Animals
5.3.2 Livestock Animals
5.3.2.1 Cattle
5.3.2.2 Swine
5.3.2.3 Poultry
5.3.2.4 Other Livestock Animals
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioMerieux SA
6.1.2 Heska Corporation
6.1.3 Idexx Laboratories
6.1.4 IDVet
6.1.5 Randox Laboratories Ltd.
6.1.6 Thermo Fisher Scientific Inc.
6.1.7 Virbac Corporation
6.1.8 Zoetis Inc.
6.1.9 BIOCHEK BV
6.1.10 INDICAL Bioscience GmbH
6.1.11 Neogen Corporation
6.1.12 Bio-Rad Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Veterinary Diagnostics Industry Segmentation
As per the scope of this report, veterinary diagnostics provide medical diagnostic testing for infectious agents, toxins, and other causes of diseases in animal diagnostic samples. The Veterinary Diagnostics Market is Segmented by Product (Instruments, Kits & Reagents, and Software & Services), Technology (Immunodiagnostics, Molecular Diagnostics, Hematology, and Other Technologies), Animal Type (Companion Animals (Dogs, Cats, and Other Companion Animals) and Livestock Animals (Cattle, Swine, Poultry and Other Livestock Animals)), and Geography (North America, Europe, Asia-Pacific, Middle East, Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
By Product Type | |
Instruments | |
Kits and Reagents | |
Software and Services |
By Technology | |
Immunodiagnostics | |
Clinical Biochemistry | |
Molecular Diagnostics | |
Hematology | |
Other Technologies |
By Animal Type | ||||||
| ||||||
|
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Veterinary Diagnostics Market Research FAQs
How big is the Veterinary Diagnostics Market?
The Veterinary Diagnostics Market size is expected to reach USD 7.94 billion in 2024 and grow at a CAGR of 9.57% to reach USD 12.55 billion by 2029.
What is the current Veterinary Diagnostics Market size?
In 2024, the Veterinary Diagnostics Market size is expected to reach USD 7.94 billion.
Who are the key players in Veterinary Diagnostics Market?
Idexx Laboratories, Zoetis, Inc, Thermo Fisher Scientific Inc, Biomérieux SA and Virbac Corporation are the major companies operating in the Veterinary Diagnostics Market.
Which is the fastest growing region in Veterinary Diagnostics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Veterinary Diagnostics Market?
In 2024, the North America accounts for the largest market share in Veterinary Diagnostics Market.
What years does this Veterinary Diagnostics Market cover, and what was the market size in 2023?
In 2023, the Veterinary Diagnostics Market size was estimated at USD 7.18 billion. The report covers the Veterinary Diagnostics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Veterinary Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the major restraints in the Veterinary Diagnostics Market?
The major restraints in the Veterinary Diagnostics Market are a) The increasing cost of pet care and imaging devices b) Lack of veterinarians.
Veterinary Diagnostics Industry Report
This comprehensive report offers a deep dive into the veterinary diagnostics industry, providing a detailed analysis of key market drivers and market segments. Mordor Intelligence offers customization based on your specific interests, including: 1. End-User: Hospitals, Clinics, POC/In-House, Labs 2. Technology: Pathology, Diagnostics Imaging, and Biochemistry